Testimony
American Hospital Association (AHA) testimonies to the United States House of Representatives, the United States Senate, and other government agencies.
AHA comments to the House Committee on Ways and Means regarding the important topic of drug shortages in the United States.
The AHA shares comments on the topic of national health expenditures before the House Committee on Energy and Commerce Subcommittee on Health .
The American Hospital Association submits comments to the Senate Committee on Finance regarding the important topic of drug shortages.
AHA Statement before the House Committee on Energy and Commerce
Subcommittee on Health on “Supporting Access to Long-Term Services and Supports: An Examination of the Impacts of Proposed Regulations on Workforce and Access to Care”
AHA shares the hospital field’s comments on legislative proposals for consideration before the Energy and Commerce Committee Health Subcommittee on Oct. 19.
AHA shares the hospital field’s experience with implementation of the No Surprises Act (NSA) before the House Committee on Ways and Means.
The American Hospital Association would like to provide feedback on sections of H.R. 4822, the “Health Care Price Transparency Act of 2023,” as well as H.R. 3284, the “Providers and Payers COMPETE Act.”
Statement
of the
American Hospital Association
for the
Committee on Education and the Workforce
Subcommittee on Health, Employment, Labor, and Pensions
of the
American Hospital Association (AHA) statement for the record to the Senate Finance Committee to provide the hospital perspective on how hospital mergers and acquisitions can expand and preserve access to quality care.
AHA statement on legislative proposals that are to be considered before the Energy and Commerce Committee on May 24.